The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACELYRIN | COM | 00445A100 | 21,556,923 | 2,889,668 | SH | SOLE | 2,889,668 | 0 | 0 | ||
ADAGENE | ADS | 005329107 | 509,890 | 264,000 | SH | SOLE | 264,000 | 0 | 0 | ||
AKERO THERAPEUTICS | COM | 00973Y108 | 41,696,422 | 1,785,714 | SH | SOLE | 1,785,714 | 0 | 0 | ||
ALIGNMENT HEALTHCARE | COM | 01625V104 | 525,152,511 | 60,993,323 | SH | SOLE | 60,993,323 | 0 | 0 | ||
ALKAMI | COM | 01644J108 | 454,197,796 | 18,729,806 | SH | SOLE | 18,729,806 | 0 | 0 | ||
BLEND LABS | CL A | 09352U108 | 48,787,722 | 19,132,440 | SH | SOLE | 19,132,440 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS | SPONSORED ADR | 152309100 | 77,067,271 | 9,681,818 | SH | SOLE | 9,681,818 | 0 | 0 | ||
CLEAR SECURE | CL A | 18467V109 | 41,894,658 | 2,028,797 | SH | SOLE | 2,028,797 | 0 | 0 | ||
DLOCAL | CL A | G29018101 | 1,130,509,435 | 63,906,695 | SH | SOLE | 63,906,695 | 0 | 0 | ||
ENGAGESMART | COM | 29283F103 | 2,067,218,266 | 90,271,540 | SH | SOLE | 90,271,540 | 0 | 0 | ||
EUROPEAN WAX CENTER | CL A | 29882P106 | 178,171,586 | 13,110,492 | SH | SOLE | 13,110,492 | 0 | 0 | ||
FUTU | SPON ADS CL A | 36118L106 | 16,894,601 | 309,255 | SH | SOLE | 309,255 | 0 | 0 | ||
GROVE COLLABORATIVE | CL A | 39957D201 | 1,656,755 | 936,020 | SH | SOLE | 936,020 | 0 | 0 | ||
HIRERIGHT | COM | 433537107 | 431,878,128 | 32,109,898 | SH | SOLE | 32,109,898 | 0 | 0 | ||
HUTCHMED | SPONSORED ADS | 44842L103 | 72,440,000 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | ||
IMMUNOCORE | ADS | 45258D105 | 64,904,000 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
KARUNA THERAPEUTICS | COM | 48576A100 | 312,303,582 | 986,710 | SH | SOLE | 986,710 | 0 | 0 | ||
MOBILEYE | CL A | 60741F104 | 57,129,636 | 1,318,782 | SH | SOLE | 1,318,782 | 0 | 0 | ||
OPENDOOR | COM | 683712103 | 28,320,405 | 6,321,519 | SH | SOLE | 6,321,519 | 0 | 0 | ||
PHARVARIS | COM | N69605108 | 172,682,869 | 6,156,252 | SH | SOLE | 6,156,252 | 0 | 0 | ||
RISKIFIED | SHS CL A | M8216R109 | 24,920,991 | 5,324,998 | SH | SOLE | 5,324,998 | 0 | 0 | ||
ROYALTY PHARMA | SHS CLASS A | G7709Q104 | 42,135,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
SQUARESPACE | CL A | 85225A107 | 350,271,520 | 10,611,073 | SH | SOLE | 10,611,073 | 0 | 0 | ||
THIRD HARMONIC BIO | COM | 88427A107 | 32,457,619 | 2,958,762 | SH | SOLE | 2,958,762 | 0 | 0 | ||
WISH | CL A | 21077C305 | 3,627,215 | 609,616 | SH | SOLE | 609,616 | 0 | 0 | ||
XP, INC | CL A | G98239109 | 772,134,299 | 29,617,733 | SH | SOLE | 29,617,733 | 0 | 0 |